IDXX vs JYNT · P/E 40, rev $2.36B vs P/E 92, rev $30.0M
IDEXX Laboratories Inc (IDXX) versus The Joint Corp (JYNT) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
The Joint Corp (JYNT) is a medical care facilities company listed on US.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported JYNT revenue for 2026-06-30 was $30.0M. Net income was $2.0M. JYNT currently screens at market cap $117.9M and trailing P/E 91.9.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. JYNT currently screens at market cap $117.9M and trailing P/E 91.9.
Not investment advice. Open the IDXX and JYNT stock pages for the full models.
Not investment advice.